FOR IMMEDIATE RELEASE
November 20, 2006 Contact: Victoria Tedeschi
Adventist Midwest Health
Cancer Trials Allow Physicians to
Break New Treatment Ground
Hinsdale, IL – Cancer patients can be assured of receiving the best, most advanced care through the Adventist Cancer Network at both Adventist La Grange Memorial Hospital and Adventist Hinsdale Hospital.
At any given time, the hospitals participate in more than 75 different clinical research studies in such areas as lung cancer, breast cancer, prostate cancer and colon cancer. Approximately 4 percent of cancer patients participate in the studies, which is above the national average of 2 percent, said Clarissa Moholick, regional manager of cancer data.
November is Lung Cancer Awareness month, and currently the hospitals are participating in 10 major studies and two associated studies testing new treatment options for lung cancer, said James Hannigan, M.D., medical director of the cancer program at Adventist La Grange Memorial Hospital. The studies are all approved by the National Cancer Institute and are developed by one of the national cancer treatment groups, such as the Cancer and Acute Leukemia Group B (CALGB) or the Southwest Oncology Group (SWOG).
The lung cancer studies include ones that study the efficacy of new medications to define more effective treatments for the disease, Hannigan said.
It is important for community hospitals such as Adventist La Grange Memorial and Adventist Hinsdale Hospital to offer their patients access to clinical trials, he added. “Previously only people who lived close to major medical centers had access to quality care for cancer,” Hannigan said. “Our involvement ensures our patients that they receive the same quality of care without having to leave their neighborhood.”
These studies allow physicians to break ground on new treatment options, said Michael Quaranta, regional director of radiology and oncology for the Adventist Cancer Network. “Participating in cancer trials ensures our patients we are giving them the best possible treatment options available at this point in time,” he said. “We can help test a new approach to managing a particular form of cancer. It’s so critical that we have physicians and patients who are willing to participate in the advancement of cancer treatment.”
Elyse Schneiderman, M.D., a hematologist/oncologist who treats patients at Adventist Hinsdale Hospital, said that the help of today’s patients will help future generations. “Our patients benefit from all the people who have participated in these trials. Their willingness to be involved benefits themselves along with future generations,” she said.